Manufacturing

Regenicin’s cultured skin substitute and related product candidates will be manufactured either in-house or through contract manufacturers. All production will take place in FDA-compliant, cGMP-certified facilities initially within the United States.

The proprietary collagen scaffolds are produced domestically using purified closed herd collagen in an FDA cGMP-compliant facility. These materials are sourced exclusively from U.S.-grown bovine, harvested in specialized FDA-compliant closed herd facilities. They adhere to ISO 20224:42 standards, Code of Federal Regulations Title 61.49919 for xenotransplantation, and meet all U.S. Department of Agriculture requirements for being “Fit for Human Consumption.”

Regenicin
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.